BPIQ Blog

Jan 4, 20235 min read

How does Lecanemab compare to other Alzheimer's assets?

Summary: Biogen and Eisai's asset Lecanemab has a PDUFA date set for Friday 1/6/23 Lecanemab targets and effectively reduces beta-amyloid...

Jul 18, 20221 min read

Biopharma Mid Morning Pulse - 07/18/22

(Posted 10:15am CST) $XBI $82.81 | +0.53% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume...

Jul 18, 20221 min read

Free Biopharma Mid Morning Pulse - 07/18/22

(Posted 10:15am CST) $XBI $82.81 | +0.53% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume...

Jump start your biotech due diligence

Our platform helps you uncover your next biotech investment opportunity